Exam OG0-093 All QuestionsBrowse all questions from this exam
Go to Exam
Question 209

Scenario:

Please read this scenario prior to answering the Question.

The ABC Ltd. is a leading medical device manufacturer in the highly competitive market for Migraine Headache Pain Management (MHPM) devices. These tiny wireless devices are implanted in the brain and can deliver a precise electric shock when the wearable Pain Control Unit (PCU) detects an increase in stress induced by the onset of a migraine headache. This technology will be a breakthrough in the treatment of this condition, and several competitors are striving to be the first to introduce a product into the market. However, all of them must demonstrate the effectiveness and safety of their products in a set of clinical trials that will satisfy the regulatory requirements of the countries in the target markets.

The Enterprise Architecture group at the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their independent clinical trials. The Enterprise

Architecture group is a mature organization that has been utilizing TOGAF for several years. The company Architecture Development Method is strictly based on

TOGAF 9 with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. The project team has now completed the Business, Information Systems, and Technology Architecture phases and has produced a complete set of deliverables for each phase. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant for each domain. A corresponding Security Architecture has been defined.

The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. He has stated that the changes to the enterprise architecture for the new system will need to be rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials. The work will need to be done in stages and rolled out in geographical regions.

Refer to the Scenario -

You are serving as the Lead Architect for the project team.

You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).

Based on TOGAF 9, which of the following is the best answer?

    Correct Answer: A

    Creating an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions, and Dependencies Matrix is the most comprehensive approach. For each gap, identifying proposed solutions and classifying them as new development, purchased solutions, or based on existing products ensures a structured methodology. Grouping similar solutions together forms cohesive work packages, and identifying dependencies between these work packages takes into account critical clinical trial schedules. Regrouping the packages into a series of Capability Increments scheduled into Transition Architectures and documented in an Architecture Definition Increments Table aligns well with minimizing disruptions and achieving a smooth transition to the target architecture.

Discussion
venksfcOption: C

C is correct. Key words in this sentence: Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.

noureldinOption: A

Ans A should better than C:C doesn't talk about transition architecture, and TOGAF recommends to "Using the Consolidated Gaps, Solutions, and Dependencies matrix together with the Implementation Factor Assessment and Deduction matrix, logically group the various activities into work packages."

Learner64

The key word is "using" which goes to C. I'd vote for C.

Learner64

Sorry. I think it is A.

OCHTOption: A

Phases Required: Phase E (Opportunities and Solutions): This is where you identify work packages and solutions. The Implementation Factor Assessment and Deduction Matrix is crucial here. Phase F (Migration Planning): This is where the work packages are grouped into Capability Increments and scheduled into a series of Transition Architectures. The Architecture Definition Increments Table is used here.

OCHT

How They Proceed: Identify Gaps: Use the Consolidated Gaps, Solutions, and Dependencies Matrix to identify gaps between the baseline and target architectures. Propose Solutions: For each gap, propose a solution and classify it as new development, purchased solution, or based on an existing product. Group Solutions: Group similar solutions together to form work packages. Identify Dependencies: Use the Implementation Factor Assessment and Deduction Matrix to identify dependencies between work packages, taking into account the clinical trial schedules. Create Capability Increments: Regroup the packages into a set of Capability Increments. Schedule Transition Architectures: Document these in an Architecture Definition Increments Table and schedule them to minimize disruptions to ongoing clinical trials.

BanzaaaiOption: C

C. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.

sreejayanOption: A

I will go with A

ankit89Option: A

A is right answer.

SomeshSuleOption: C

"taking into account the schedule for clinical trials" this line seems important to minimize disruptions to ongoing trials, hence C looks ok.

sushmapatilOption: A

A should be correct ? since its covers all artifacts of Phase E along with Capability Increments for staged approach.

qinnnyulOption: A

it looks like A makes more sense to me? key words: work package

caerzzOption: A

A covers the Implementation Factor Assessment and Deduction Matrix and Consolidated Gaps, Solutions, & Dependencies Matrix

Elisa2021Option: A

Answer A is appropriate with steps in Phase E : refer to TOGF 9.2 Standard Book , Chapter 12.3 steps

PrashanttheCloudMasterOption: A

As per understanding , solution sequence --- > A C D B

RishoOption: C

should it not be C when creating work packages, Consolidated Gaps, Solutions, and Dependencies Matrix

SanthoshLVOption: D

D is the answer I am more inclined towards

SanthoshLV

Nevermind. Pls ignore my opinion, Solution building blocks can't be combined in any random order to form a transition architecture. So guess its A or C then

thirstylionOption: A

Answer: A Refer ADM Guideline and Techniques 24 Migration Planning Techniques

sanjepauOption: A

A should be the correct answer as the techniques mentioned deal with Security. Like the Deductions Matrix and Consolidated, Gap, Solution.

KMurthy04Option: A

A is the correct answer because Consolidated gaps assessment and dependency matrix and Implementation factor assessment and deduction matrix together help to logically group the packages (Refernce: 12.3.9- Identify major work packages)